About Fluorous Technologies
Fluorous Technologies is a company based in United States founded in 2000 was acquired by Boron Specialties in December 2013. Fluorous Technologies has raised $3 million across 6 funding rounds from investors including HHS, Curia and Innovation Works. Fluorous Technologies operates in a competitive market with competitors including ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others.
- Headquarter United States
- SectorsHealthcare
- Email••••••••
- Website fluorous.com
- Social LinkedIn
- Acquired by Boron Specialties (Dec 2013)
- Total Equity Funding$3M (USD)
in 6 rounds
- Latest Funding Round$1.11M (USD), Grant
Sep 2009
- InvestorsHHS
& 4 more
- Acquired byBoron Specialties
(Dec 2013)
Funding Insights of Fluorous Technologies
Fluorous Technologies has successfully raised a total of $3M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.11 million completed in September 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 6
- Last Round Grant — $1.11M
- First Round $3M
(Jun 2003)
- Investors Count 4
All 6 funding rounds of Fluorous Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2009 | $1.11M | Grant | – | – | |
| Sep 2009 | $898,161 | Grant | – | – | |
| Sep 2009 | $898,161 | Grant | – | – | |
| Sep 2007 | $1.11M | Grant | – | – | |
| Aug 2007 | $898,161 | Grant | – | – | |
| Jun 2003 | $3M | Series A | – | Innovation Works, Fairview Capital | – |
5 investors in total: 5 institutional.
Investors in Fluorous Technologies
Fluorous Technologies has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Curia and Innovation Works.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Software, hardware, and life sciences startups are funded and accelerated. | 1999 | innovationworks.org | Pittsburgh, United States | |
No specific activity is described for Fairview Capital. | – | fairviewcapital.com | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Drug research, development, testing, and consulting services are provided. | 1991 | curiaglobal.com | Albany, United States | |
- | – | boron.com | - |
Investor details for Fluorous Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fluorous Technologies
1 people are tracked at Fluorous Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Philip Yeske | ex-CEO | Leadership |
Complete people profiles for Fluorous Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Fluorous Technologies
4 dated milestones of Fluorous Technologies across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Fluorous Technologies is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Grant, of $1.1M.
- Exit Acquired by Boron Specialties.
Competitors of Fluorous Technologies
Fluorous Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromatan.com | 2009 | State College, United States | $5.32M | – | Continuous countercurrent tangential chromatography separation technology is developed. | |
| reachseparations.com | 2011 | Nottingham, United Kingdom | – | 16 | Small molecule analysis and purification services are provided using chromatography. | |
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| knauer.net | 1962 | Berlin, Germany | – | – | Provides liquid chromatography solutions | |
| sepragen.com | 1987 | Hayward, United States | $5M | 19 | Biomolecular separation technologies are enabled for bioprocessing applications. | |
| biaseparations.com | 1998 | Villach, Austria | $1.69M | 2 | Monolithic chromatographic columns are developed using Convective Interaction Media technology. | |
| sembabio.com | 2005 | Madison, United States | $5.85M | – | Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC) | |
| upfront-dk.com | 1992 | Copenhagen, Denmark | $32.27M | 5 | Chromatography technologies for protein separation and biomolecule recovery are provided. | |
| pharmafluidics.com | 2010 | Ghent, Belgium | – | 14 | Microchip liquid chromatography cartridges are supplied for nano-LC applications. | |
| indigobio.com | 2004 | Indianapolis, United States | $12.35M | 27 | Laboratory automation software is developed by Indigo BioAutomation. |
Detailed competitors of Fluorous Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fluorous Technologies
Websites that share an audience with Fluorous Technologies (fluorous.com).
Websites whose visitors overlap most with Fluorous Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
chemreagent.com | chemreagent.com | 100% | – | – | – |
| borochem.fr | 100% | – | – | View details | |
ds-chem.com | ds-chem.com | 100% | – | – | – |
hvchemical.com | hvchemical.com | 100% | – | #12,187,312 | – |
| gesanproduction.it | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Fluorous Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Fluorous Technologies
10 companies that operate in the same segment as Fluorous Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fluorous Technologies
Fluorous Technologies was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Fluorous Technologies is headquartered in United States.
Philip Yeske is the current CEO of Fluorous Technologies.
Fluorous Technologies is a funded company, having raised a total of $3M across 6 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Jun 2003.
Fluorous Technologies was founded in 2000 in the United States, operating within the life sciences sector. Tools for synthesis, purification, enrichment, and immobilization of small molecules, peptides, carbohydrates, and oligonucleotides are offered. Products include SPE cartridges, HPLC columns, sorbent materials, and Rf8 homologs such as F-Boc-ON, F-silane, F-benzyl alcohol, F-thiol, F-propylamine, F-isocyanate, F-iodide, F-propanol, F-carboxylic acid, along with biomolecule tags and reagents.
Fluorous Technologies's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Fluorous Technologies has 5 investors. Key investors include HHS, Curia, Innovation Works, Fairview Capital, and Boron Specialties.
Yes. Fluorous Technologies was acquired by Boron Specialties in December 2013.